Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective

Despite some indicators of a localized curtailing of cardiovascular disease (CVD) prevalence, CVD remains one of the largest contributors to global morbidity and mortality. While the magnitude and impact of the coronavirus dis-ease 2019 (COVID-19) pandemic have yet to be realized in its entirety, an unquestionable impact on global health and well-being is already clear. At a time when the global state of CVD is perilous, we provide a continental over-view of prevalence data and initiatives that have positively influenced CVD outcomes. What is clear is that despite attempts to address the global burden of CVD, there remains a lack of collective thinking and approaches. Moving forward, a coordinated global infrastructure that, if developed with appropriate and relevant key stakeholders, could provide significant and longstanding benefits to public health and yield prominent and consistent policy re-sulting in impactful change. To achieve global impact, research priorities that address multi-disciplinary social, en-vironmental, and clinical perspectives must be underpinned by unified approaches that maximize public health.(c) 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).

Automated summary

Despite some localized decrease in cardiovascular disease (CVD) prevalence, CVD remains a major global health issue. The impact of the COVID-19 pandemic on global health is already evident. This article provides an overview of prevalence data and initiatives that have positively influenced CVD outcomes, highlighting the need for a coordinated global infrastructure to address CVD collectively and maximize public health.